Читать книгу The SAGE Encyclopedia of Stem Cell Research - Группа авторов - Страница 251

A number of drugs that target HER2 are currently in use, including trastuzumab (Herceptin), pertuzumab (Perjeta), ado-trastuzumab emtansine (Kadcyla), and lapatinib (Tykerb).